Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 16, 2018 Filed Aug 17, 2018 14:42 UTC |
Rootsaert Rodney GerardSecretary
|
PurchaseCommon Stock | 5,000 | $1.91 | $9,550.00 |
DisclosureSEC source: 0001078782-18-000887 · primary_doc.xml · nonDerivative · entry 1 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,828 Read SEC document |
| August 16, 2018 Filed Aug 17, 2018 14:39 UTC |
Reynolds Cameron JohnDirector · President and CEO
|
PurchaseCommon Stock | 6,500 | $1.91 | $12,415.00 |
DisclosureSEC source: 0001078782-18-000886 · primary_doc.xml · nonDerivative · entry 1 Reynolds Cameron John · CIK 0001340610 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,121,173 Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 14:27 UTC |
Innes Guy ArchibaldDirector
|
PurchaseCommon Stock | 49,826 | $2.00 | $99,652.00 |
DisclosureSEC source: 0001078782-18-000900 · primary_doc.xml · nonDerivative · entry 4 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,354,975 Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 14:27 UTC |
Innes Guy ArchibaldDirector
|
PurchaseCommon Stock | 14 | $1.99 | $27.86 |
DisclosureSEC source: 0001078782-18-000900 · primary_doc.xml · nonDerivative · entry 3 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,305,149 Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 14:27 UTC |
Innes Guy ArchibaldDirector
|
PurchaseCommon Stock | 7 | $1.97 | $13.79 |
DisclosureSEC source: 0001078782-18-000900 · primary_doc.xml · nonDerivative · entry 2 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,305,135 Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 14:27 UTC |
Innes Guy ArchibaldDirector
|
PurchaseCommon Stock | 153 | $1.95 | $298.35 |
DisclosureSEC source: 0001078782-18-000900 · primary_doc.xml · nonDerivative · entry 1 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,305,128 Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 22:28 UTC |
Micallef Jacob VincentChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-18-000074 · primary_doc.xml · derivative · entry 1 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2024-01-23 F1 · derivative.exercise_date: A total of 75,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 22:23 UTC |
TERRELL JASON BRADLEY MDChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-18-000073 · primary_doc.xml · derivative · entry 1 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-01-23 F1 · derivative.exercise_date: A total of 50,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 22:16 UTC |
Faulkes Martin CharlesDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-18-000072 · primary_doc.xml · derivative · entry 1 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-01-23 F1 · derivative.exercise_date: A total of 50,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 22:10 UTC |
Rootsaert Rodney GerardSecretary
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-18-000071 · primary_doc.xml · derivative · entry 1 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-01-23 F1 · derivative.exercise_date: A total of 50,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 22:04 UTC |
Colman AlanDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-18-000070 · primary_doc.xml · derivative · entry 1 Colman Alan · CIK 0001577873 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2024-01-23 F1 · derivative.exercise_date: A total of 30,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 21:47 UTC |
Reynolds Cameron JohnDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-18-000069 · primary_doc.xml · derivative · entry 1 Reynolds Cameron John · CIK 0001340610 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2024-01-23 F1 · derivative.exercise_date: A total of 75,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 21:39 UTC |
Vanston David CecilChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-18-000068 · primary_doc.xml · derivative · entry 1 Vanston David Cecil · CIK 0001703012 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2024-01-23 F1 · derivative.exercise_date: A total of 60,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 21:28 UTC |
Futcher EdwardDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-18-000067 · primary_doc.xml · derivative · entry 1 Futcher Edward · CIK 0001222623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2024-01-23 F1 · derivative.exercise_date: A total of 10,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 21:21 UTC |
Skaff HabibDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-18-000066 · primary_doc.xml · derivative · entry 1 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2024-01-23 F1 · derivative.exercise_date: A total of 10,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 18:06 UTC |
Innes Guy ArchibaldDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-18-000065 · primary_doc.xml · derivative · entry 1 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2024-01-23 F1 · derivative.exercise_date: A total of 20,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 20:33 UTC |
TERRELL JASON BRADLEY MDChief Medical Officer
|
GrantWarrant (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.47 | $0.00 |
DisclosureSEC source: 0001078782-17-001449 · primary_doc.xml · derivative · entry 1 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2020-09-18 F1 · balance_after: The vesting criteria of one installment of a Warrant granted to the reporting person on March 20, 2013, was deemed met pursuant to approval of the Compensation Committee of the Issuer effective October 18, 2017, resulting in vesting of the Warrant as to 25,000 shares effective September 18, 2017. The vested shares shall expire three years after the vesting date. Read SEC document |
| September 19, 2017 Filed Sep 19, 2017 20:28 UTC |
Vanston David CecilCHIEF FINANCIAL OFFICER
|
PurchaseCOMMON STOCK | 2,750 | $2.84 | $7,810.00 |
DisclosureSEC source: 0001078782-17-001281 · primary_doc.xml · nonDerivative · entry 1 Vanston David Cecil · CIK 0001703012 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,750 Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 20:08 UTC |
Reynolds Cameron JohnDirector · President and CEO
|
PurchaseCommon Stock | 3,630 | $2.77 | $10,055.10 |
DisclosureSEC source: 0001078782-17-001160 · primary_doc.xml · nonDerivative · entry 1 Reynolds Cameron John · CIK 0001340610 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Concord International, Inc. Disclosed balance after: 1,007,718 F1 · ownership.nature: The shares of Common Stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of Common Stock held by Concord International, Inc. Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 20:11 UTC |
Rootsaert Rodney GerardSecretary
|
PurchaseCommon Stock | 3,630 | $2.77 | $10,055.10 |
DisclosureSEC source: 0001078782-17-001161 · primary_doc.xml · nonDerivative · entry 1 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · Concord International, Inc. Disclosed balance after: 1,007,718 F1 · ownership.nature: The shares of Common Stock are held directly by Concord International, Inc. Mr. Rootsaert is a controlling director of Concord International, Inc. and shares voting and dispositive control over the shares of Common Stock held by Concord International, Inc. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:33 UTC |
Skaff HabibDirector
|
OtherWarrant (Right to Buy) · Derivative | 3,143 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001078782-17-000604 · primary_doc.xml · derivative · entry 2 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,143 shares Expires 2017-05-10 F1 · derivative.underlying_shares: On May 5, 2017, the Reporting Person exercised a warrant to purchase 3,143 shares of Common Stock of the issuer for $2.60 per share. The warrant was set to expire pursuant to its terms on May 10, 2017. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:33 UTC |
Skaff HabibDirector
|
OtherCommon Stock | 3,143 | $2.60 | $8,171.80 |
DisclosureSEC source: 0001078782-17-000604 · primary_doc.xml · nonDerivative · entry 1 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,542 F1 · balance_after: On May 5, 2017, the Reporting Person exercised a warrant to purchase 3,143 shares of Common Stock of the issuer for $2.60 per share. The warrant was set to expire pursuant to its terms on May 10, 2017. Read SEC document |
| April 18, 2017 Filed Apr 19, 2017 21:12 UTC |
Innes Guy ArchibaldDirector
|
OtherWarrant (Right to Buy) · Derivative | 1,786 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001078782-17-000520 · primary_doc.xml · derivative · entry 4 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,786 shares Expires 2017-05-10 F2 · derivative.underlying_shares: On April 18, 2017, a bare trust, of which the Reporting Person is the Trustee, exercised a warrant to purchase 1,786 shares of Common Stock of the issuer for $2.60 per share. The warrant was set to expire pursuant to its terms on May 10, 2017. F3 · ownership.nature: The foregoing shares and warrants are held by a bare trust, which is not a separate legal entity, of which Mr. Innes is the Trustee, for the benefit of certain minors. Read SEC document |
| April 18, 2017 Filed Apr 19, 2017 21:12 UTC |
Innes Guy ArchibaldDirector
|
OtherWarrant (Right to Buy) · Derivative | 74,821 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001078782-17-000520 · primary_doc.xml · derivative · entry 3 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 74,821 shares Expires 2017-05-10 F1 · derivative.underlying_shares: On April 18, 2017, the Reporting Person exercised a warrant to purchase 74,821 shares of Common Stock of the issuer for $2.60 per share. The warrant was set to expire pursuant to its terms on May 10, 2017. Read SEC document |
| April 18, 2017 Filed Apr 19, 2017 21:12 UTC |
Innes Guy ArchibaldDirector
|
OtherCommon Stock | 1,786 | $2.60 | $4,643.60 |
DisclosureSEC source: 0001078782-17-000520 · primary_doc.xml · nonDerivative · entry 2 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 49,726 F2 · balance_after: On April 18, 2017, a bare trust, of which the Reporting Person is the Trustee, exercised a warrant to purchase 1,786 shares of Common Stock of the issuer for $2.60 per share. The warrant was set to expire pursuant to its terms on May 10, 2017. F3 · ownership.nature: The foregoing shares and warrants are held by a bare trust, which is not a separate legal entity, of which Mr. Innes is the Trustee, for the benefit of certain minors. Read SEC document |
| April 18, 2017 Filed Apr 19, 2017 21:12 UTC |
Innes Guy ArchibaldDirector
|
OtherCommon Stock | 74,821 | $2.60 | $194,534.60 |
DisclosureSEC source: 0001078782-17-000520 · primary_doc.xml · nonDerivative · entry 1 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,304,975 F1 · balance_after: On April 18, 2017, the Reporting Person exercised a warrant to purchase 74,821 shares of Common Stock of the issuer for $2.60 per share. The warrant was set to expire pursuant to its terms on May 10, 2017. Read SEC document |
| April 10, 2017 Filed Apr 11, 2017 20:11 UTC |
Vanston David CecilChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000451 · primary_doc.xml · derivative · entry 1 Vanston David Cecil · CIK 0001703012 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2023-04-10 F1 · derivative.exercise_date: A total of 100,000 Options were granted on April 10, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 21:19 UTC |
Faulkes Martin CharlesDirector
|
OtherWarrant (Right to Buy) · Derivative | 58,034 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001078782-17-000428 · primary_doc.xml · derivative · entry 2 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,034 shares Expires 2017-05-10 Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 21:19 UTC |
Faulkes Martin CharlesDirector
|
OtherCommon Stock | 58,034 | $2.60 | $150,888.40 |
DisclosureSEC source: 0001078782-17-000428 · primary_doc.xml · nonDerivative · entry 1 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,351,284 Read SEC document |
| March 30, 2017 Filed Apr 3, 2017 20:37 UTC |
Faulkes Martin CharlesDirector
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000414 · primary_doc.xml · derivative · entry 1 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2023-03-30 F1 · derivative.exercise_date: A total of 100,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| March 30, 2017 Filed Apr 3, 2017 20:41 UTC |
TERRELL JASON BRADLEY MDChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000415 · primary_doc.xml · derivative · entry 1 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2023-03-30 F1 · derivative.exercise_date: A total of 50,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| March 30, 2017 Filed Apr 3, 2017 20:33 UTC |
Rootsaert Rodney GerardSecretary
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000413 · primary_doc.xml · derivative · entry 1 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2023-03-30 F1 · derivative.exercise_date: A total of 60,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| March 30, 2017 Filed Apr 3, 2017 20:27 UTC |
Reynolds Cameron JohnDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000411 · primary_doc.xml · derivative · entry 1 Reynolds Cameron John · CIK 0001340610 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2023-03-30 F1 · derivative.exercise_date: A total of 100,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| March 30, 2017 Filed Apr 3, 2017 20:30 UTC |
Colman AlanDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000412 · primary_doc.xml · derivative · entry 1 Colman Alan · CIK 0001577873 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2023-03-30 F1 · derivative.exercise_date: A total of 20,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| March 30, 2017 Filed Apr 3, 2017 20:23 UTC |
Futcher EdwardDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000410 · primary_doc.xml · derivative · entry 1 Futcher Edward · CIK 0001222623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2023-03-30 F1 · derivative.exercise_date: A total of 15,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| March 30, 2017 Filed Apr 3, 2017 20:20 UTC |
Innes Guy ArchibaldDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000409 · primary_doc.xml · derivative · entry 1 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2023-03-30 F1 · derivative.exercise_date: A total of 20,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| March 30, 2017 Filed Apr 3, 2017 20:17 UTC |
Skaff HabibDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000408 · primary_doc.xml · derivative · entry 1 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2023-03-30 F1 · derivative.exercise_date: A total of 15,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| March 30, 2017 Filed Apr 3, 2017 20:13 UTC |
Micallef Jacob VincentChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000407 · primary_doc.xml · derivative · entry 1 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2023-03-30 F1 · derivative.exercise_date: A total of 70,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 20:18 UTC |
Micallef Jacob VincentChief Scientific Officer
|
SaleWarrant (Right to Buy) · Derivative | 5,000 | $2,000.00 Strike: $2.60 | $10,000,000.00 |
DisclosureSEC source: 0001078782-17-000337 · primary_doc.xml · derivative · entry 1 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Borlaug Limited Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2017-05-10 F1 · ownership.nature: The Warrant is held directly by Borlaug Limited. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of Common Stock issuable upon the exercise of the Warrant. Dr. Micallef disclaims beneficial ownership of the shares of Common Stock issuable upon the exercise of the Warrant, except to the extent of his pecuniary interest. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 18:11 UTC |
TERRELL JASON BRADLEY MDChief Medical Officer
|
GrantWarrant (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.47 | $0.00 |
DisclosureSEC source: 0001078782-17-000206 · primary_doc.xml · derivative · entry 2 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · kind: The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The replacement warrant amends the performance criteria for a vesting milestone. F2 · derivative.exercise_date: The date exercisable is variable and depends on the achievement of the performance criteria outlined in the warrant agreement, as amended. F3 · derivative.expiration_date: The subject warrant shall expire three years after the vesting date. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 18:11 UTC |
TERRELL JASON BRADLEY MDChief Medical Officer
|
Disposition to issuerWarrant (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.47 | $0.00 |
DisclosureSEC source: 0001078782-17-000206 · primary_doc.xml · derivative · entry 1 TERRELL JASON BRADLEY MD · CIK 0001567531 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · kind: The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The replacement warrant amends the performance criteria for a vesting milestone. F2 · derivative.exercise_date: The date exercisable is variable and depends on the achievement of the performance criteria outlined in the warrant agreement, as amended. F3 · derivative.expiration_date: The subject warrant shall expire three years after the vesting date. Read SEC document |
| November 25, 2016 Filed Nov 28, 2016 21:06 UTC |
Faulkes Martin CharlesDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-16-003867 · primary_doc.xml · derivative · entry 3 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2016-11-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2016 Filed Nov 28, 2016 21:06 UTC |
Faulkes Martin CharlesDirector
|
Tax withholdingCommon Stock | 3,379 | $4.44 | $15,002.76 |
DisclosureSEC source: 0001078782-16-003867 · primary_doc.xml · nonDerivative · entry 2 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,293,250 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| November 25, 2016 Filed Nov 28, 2016 21:06 UTC |
Faulkes Martin CharlesDirector
|
Exercise / conversionCommon Stock | 5,000 | $3.00 | $15,000.00 |
DisclosureSEC source: 0001078782-16-003867 · primary_doc.xml · nonDerivative · entry 1 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,296,629 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2016 Filed Nov 23, 2016 19:55 UTC |
Colman AlanDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-16-003860 · primary_doc.xml · derivative · entry 3 Colman Alan · CIK 0001577873 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2016-11-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2016 Filed Nov 23, 2016 19:55 UTC |
Colman AlanDirector
|
Tax withholdingCommon Stock | 3,449 | $4.35 | $15,003.15 |
DisclosureSEC source: 0001078782-16-003860 · primary_doc.xml · nonDerivative · entry 2 Colman Alan · CIK 0001577873 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,250 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| November 22, 2016 Filed Nov 23, 2016 19:55 UTC |
Colman AlanDirector
|
Exercise / conversionCommon Stock | 5,000 | $3.00 | $15,000.00 |
DisclosureSEC source: 0001078782-16-003860 · primary_doc.xml · nonDerivative · entry 1 Colman Alan · CIK 0001577873 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,699 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 21:28 UTC |
Rootsaert Rodney GerardSecretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-16-003846 · primary_doc.xml · derivative · entry 3 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2016-11-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 21:28 UTC |
Rootsaert Rodney GerardSecretary
|
Tax withholdingCommon Stock | 6,697 | $4.48 | $30,002.56 |
DisclosureSEC source: 0001078782-16-003846 · primary_doc.xml · nonDerivative · entry 2 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,828 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 21:28 UTC |
Rootsaert Rodney GerardSecretary
|
Exercise / conversionCommon Stock | 10,000 | $3.00 | $30,000.00 |
DisclosureSEC source: 0001078782-16-003846 · primary_doc.xml · nonDerivative · entry 1 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.